Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,042.50    0.50 (0.05%)
Bid:
1,040.50
Ask:
1,041.50
Spread: 1.00 (0.096%)
Market Cap: £5.10b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Trading Update

25 Sep 2019 07:00

RNS Number : 5383N
Babcock International Group PLC
25 September 2019
Β 

25 September 2019

Babcock International Group PLC (Babcock or the Group)

Babcock, the aerospace and defence company, is issuing the following trading update for the period from 1 April 2019.

Trading update

Trading across the Group is in line with our expectations.

Β 

Our Marine sector is performing well with increased activity across our UK warship support business and strong orders across our technology businesses. The Queen Elizabeth Class (QEC) programme is nearing completion with HMS Prince of Wales leaving Rosyth for sea trials while our Type 23 frigate life extension programme continues to progress. In Australia and Canada we continued to make good progress on our submarine and surface ship sustainment programmes. In Land, we are continuing to make good progress across our Defence Support Group (DSG) business and have successfully transitioned to the new CP6 contract in Rail. We have also seen an improvement in our South African business.

Β 

In Nuclear, activity levels have increased across defence though the civil nuclear market remains challenging. As expected, the Magnox contract transitioned to the Nuclear Decommissioning Authority at the end of August. In Aviation, we saw the successful start of our new international businesses in Canada and Norway and have made continued progress across our military businesses. While we have seen some delays in the award of new contracts in Aviation, overall bidding activity across the sector has increased.

Β 

Contract awards

The Group continued to win work across all sectors in the period, with win rates in line with our targets.

Β 

The highlight in the period was our selection as the preferred bidder for the Type 31 general-purpose frigate programme, which will provide the UK with a fleet of five new warships for Β£1.25 billion. The ships will be assembled at Babcock's Rosyth facility, and involve supply chains throughout the UK. Work will begin immediately following formal contract award later this financial year, with detailed design work to start now and manufacture commencing in 2021 and concluding in 2027.

Β 

Expectations for the year

We confirm our full year guidance for revenue, operating profit and free cash flow as set out in May 2019, including the phasing between the first and second halves of the year, especially for cash generation. We expect the first half to reflect the phasing of previously communicated step downs1, the normal seasonality of our business and last year's phasing of Fomedec equipment sales in our Aviation business.

Β 

Refinancing completed

During the period, both Standard & Poor's and DBRS confirmed the Group's credit rating of BBB following their annual credit reviews. We renewed our 5-year Revolving Credit Facility of up to Β£775 million and issued €550 million (c.Β£500 million) of 8-year bonds expiring in 2027.

Β 

As already announced, the estimated impact of this is to increase finance costs by around Β£5 million in FY20 and around Β£7 million in FY21 and reduce finance costs by around Β£2 million each year in the years following.

Β 

ends

Β 

Β 

For further information please contact:

Babcock International Group PLC

Simon McGough

Kate Hill

Director of Investor Relations

Group Director of Communications

Tel: +44 (0)20 3823 5592

Tel: +44 (0)20 7355 5312

FTI Consulting

Andrew Lorenz, Nick Hasell

Tel: +44 (0)20 3727 1340

Β 

Β 

Conference call

A conference call for analysts and investors will be held at 08:00 (UK time) this morning, hosted by Archie Bethel (Chief Executive) and Franco Martinelli (Group Finance Director).

Β 

Webcast link:

www.babcockinternational.com/investors/results-and-presentationsΒ 

Β 

Live call:

Standard International Access

+44 (0) 20 3003 2666

UK Toll Free

0808 109 0700

Replay (available for 7 days):

Standard International Access

+44 (0) 20 8196 1480

UK Toll Free

0800 633 8453

PIN

4072877#

Β 

A transcript will be made available at www.babcockinternational.com/investors.

Β 

Β 

Notes

1. As stated in May 2019:

a. Revenue step downs for the full year of Β£410 million (QEC Β£80 million, Magnox Β£256 million, exit and disposals Β£74 million). The first half impact is expected to be around Β£150 million.

b. Operating profit step downs for the full year of Β£63 million (QEC Β£2 million, Magnox Β£24 million, Holdfast Β£17 million, exits and disposals Β£10 million and Brexit-related Aviation restructuring costs of Β£10 million). The first half impact is expected to be around Β£35 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTSEMFALFUSEEU
Date   Source Headline
1st Aug 20147:00 amRNSContract Award
29th Jul 20147:00 amRNSBoard Changes
21st Jul 20144:01 pmRNSResult of AGM
21st Jul 20147:00 amRNSInterim Management Statement
3rd Jul 201412:00 pmRNSHolding(s) in Company
30th Jun 20141:35 pmRNSCompletion of Acquisition
30th Jun 201410:48 amRNSTotal Voting Rights
26th Jun 20141:00 pmRNSDirector/PDMR Shareholding
25th Jun 20147:00 amRNSContract Announcement
17th Jun 20143:04 pmRNSAnnual Financial Report
13th Jun 201411:51 amRNSHolding(s) in Company
13th Jun 201410:54 amRNSDirector/PDMR Shareholding
11th Jun 20149:00 amRNSListing Application
9th Jun 20144:03 pmRNSRe Contracts
21st May 20148:59 amRNSDirector/PDMR Shareholding
19th May 20147:00 amRNSFull Year Results
16th May 201412:48 pmRNSDirector/PDMR Shareholding
16th May 201411:22 amRNSCompletion of Acquisition
12th May 20147:00 amRNSPreferred Bidder - Network Rail contract
9th May 201410:14 amRNSHolding(s) in Company
7th May 201410:46 amRNSDirector/PDMR Shareholding
7th May 201410:41 amRNSTotal Voting Rights
7th May 201410:16 amRNSResult of Rump Placing
7th May 20147:00 amRNSResults of Rights Issue
2nd May 201411:59 amRNSDirector/PDMR Shareholding
1st May 20142:07 pmRNSDirector/PDMR Shareholding
30th Apr 201411:49 amRNSHolding(s) in Company
25th Apr 20144:27 pmRNSReceipt of Regulatory Approval
24th Apr 20141:26 pmRNSDirector/PDMR Shareholding
17th Apr 20147:00 amRNSAdmission of Nil Paid Rights
16th Apr 201412:45 pmRNSEGM Statement
4th Apr 201412:08 pmRNSBlocklisting Interim Review
1st Apr 20147:00 amRNSContract Award
31st Mar 201410:30 amRNSPreferred Bidder Announcement
27th Mar 20143:42 pmRNSPublication of Prospectus
27th Mar 20147:00 amRNSAcquisition
21st Mar 201410:00 amRNSBoard Change
28th Feb 20147:02 amRNSDirector Declaration
12th Feb 201410:00 amRNSRe: Network Rail Contract
11th Feb 20147:00 amRNSInterim Management Statement
15th Jan 201412:07 pmRNSHolding(s) in Company
17th Dec 20137:00 amRNSAcquisition of Context Information Security
6th Dec 201310:00 amRNSNew Board Appointment
25th Nov 20137:00 amRNSStatement regarding Avincis
12th Nov 20137:00 amRNSHalf Yearly Report
30th Sep 20132:59 pmRNSBlocklisting Interim Review
27th Sep 20137:00 amRNSCapital Markets Seminar and Trading Update
16th Aug 20131:02 pmRNSDirector/PDMR Shareholding
14th Aug 20133:50 pmRNSDirector/PDMR Shareholding
14th Aug 20133:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.